Z-1091-2022 Class II Ongoing

Recalled by Neuralynx Inc — Bozeman, MT

FDA device recall Z-1091-2022 was initiated by Neuralynx Inc on Mar 14, 2022 and is designated Class II. Reason for recall: Atlas Stim Headbox (ASHB) was delivered to US customers under a premise that the device had an Investigational Device Exemption (IDE) and was for research use only, but the manufacturer does not… The recall status is ongoing. Affected quantity: 15.

Recall Details

Product Type
Devices
Report Date
May 25, 2022
Initiation Date
Mar 14, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15

Product Description

ATLAS Stim Headbox-NK For use only with the ATLAS Neurophysiology System. CAUTION--INVESTIGATIONAL DEVICE Limited by Federal (or United States) law to investigational use. Only for use in Non-Significant Risk studies under the supervision of an IRB.

Reason for Recall

Atlas Stim Headbox (ASHB) was delivered to US customers under a premise that the device had an Investigational Device Exemption (IDE) and was for research use only, but the manufacturer does not have an approved IDE by the FDA. The product has not undergone electrical safety testing and has not received regulatory clearance.

Distribution Pattern

U.S. Nationwide distribution in the states of AL, CA, IL, MN, NC, RI.

Code Information

ASHB Part No. 31-0601-0077 (SN0001, SN0002, SN0004, SN0005, SN0006, SN0007, SN0008, SN0009, SN0010, SN0012); ASHB Part No. 31-0601-0132(SN0003, SN0005, SN0006); ASHB Part No. 31-0601-0089(SN0004, SN0006);

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1091-2022
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.